Blood Pressure-Lowering Treatment Based on Cardiovascular Risk: A Meta-Analysis of Individual Patient Data

Study Questions:

Are the benefits of blood pressure (BP)-lowering drugs proportional to baseline cardiovascular risk, and can absolute risk be used to inform treatment decisions for BP-lowering therapy, as is recommended for lipid-lowering therapy?